Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii

The treatment of life-threatening infections due to carbapenem-resistant Acinetobacter baumannii has become a serious challenge for physicians worldwide. Often, only colistin shows in general good in vitro activity against these carbapenem-resistant strains, but its antibacterial efficacy in compari...

Full description

Saved in:

Bibliographic Details
Main Authors:	Montero, A., Ariza, J., Corbella, X., Doménech, A., Cabellos, C., Ayats, J., Tubau, F., Ardanuy, C., Gudiol, F.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology 2002
Subjects:	Experimental Therapeutics
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC127272/ https://ncbi.nlm.nih.gov/pubmed/12019113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1946-1952.2002
Tags:	Add Tag No Tags, Be the first to tag this record!

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii

Similar Items